Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
46,974,230
-
Shares change
-
+46,974,200
-
Total reported value, excl. options
-
$1,714,334,294
-
Value change
-
+$1,714,333,294
-
Number of buys
-
74
-
Price
-
$36.5
Significant Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q2 2021
77 filings reported holding RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share as of Q2 2021.
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,974,230 shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (18,521,000 shares), Laurion Capital Management LP (3,858,617 shares), VANGUARD GROUP INC (2,683,107 shares), ARK Investment Management LLC (2,378,675 shares), FMR LLC (2,211,601 shares), HARVARD MANAGEMENT CO INC (1,509,254 shares), CREDIT SUISSE AG/ (1,449,585 shares), BlackRock Inc. (1,444,078 shares), MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC (1,388,889 shares), and ALLIANCEBERNSTEIN L.P. (1,299,922 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.